You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Development of composition and technology of the new anti-ischemic drug product
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-C-069-Monday
- By: TESLEV, Andrey (Saint Petersburg State Chemical-Pharmaceutical Academy, Center of Pharmaceutical Technology, Saint Petersburg, Russian Federation)
- Co-author(s): Andrey Teslev: Center of Pharmaceutical Technology, Saint Petersburg State Chemical-Pharmaceutical Academy, Saint Petersburg, Russian Federation
Dmitriy Ivkin: Center of Experimental Pharmacology, Saint Petersburg State Chemical-Pharmaceutical Academy, Saint Petersburg, Russian Federation - Abstract:
Backgrounds
Ischemic heart disease and its acute forms - myocardial infarction and unstable angina - are widespread nowadays and are characterised by a high risk of death.Aims
Development of formulation, technological approaches and quality control techniques for film-coated tablets of 4-(3-ethoxy-3-oxopropanamido)benzoic acidMethods
Physical,.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026